Delivery Order SPE2DB22D9367-SPE2DB24FSV93
- Not listed
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,258.56 firm fixed-price contract is for the procurement of ADCETRIS 50 MG vials, with a period of performance through May 22, 2024. DMS Pharmaceutical Group holds a single-award, indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which allows the agency to issue delivery...
- This is a $61,258.56 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The order is for the supply of ADCETRIS 50 MG vials, a chemotherapy drug, with a performance period extending through April 2024. This award is under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with DLA, contract number SPE2DB-13-D-4600, which has a maximum value of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $45,943.92, is for the delivery of ADCETRIS 50 MG VIALS, a cancer treatment drug, to support the recurring medical supply needs of military health facilities. The delivery order is part of a larger indefinite delivery contract (IDC) that DMS Pharmaceutical...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $15,314.66 contract is for the delivery of ADCETRIS 50 MG VIALS and has a completion date of December 10, 2024. DMS Pharmaceutical Group holds a large Indefinite Delivery Contract (IDC) worth up to $499,999,999 with the DLA under the SPE2DB program. This IDC allows the DLA to issue...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $45,943.92 contract is for the delivery of ADCETRIS 50 MG VIALS, a specialized oncology medication, with a completion date of February 7, 2024. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $22,971.96 firm fixed-price contract is for the delivery of ADCETRIS 50 MG vials, a chemotherapy drug. The contract has an ultimate completion date of April 22, 2024. DMS Pharmaceutical Group Inc. holds a separate indefinite delivery contract with the DLA under the SPE2DB program, valued at up to...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,479.16 contract is for the delivery of ADCETRIS 50 MG VIALS, a specialized oncology medication, to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is valued at $45,943.92 and has an ultimate completion date of August 12, 2024. The contract is for the delivery of the pharmaceutical drug ADCETRIS 50 MG VIALS and does not have a set-aside designation. DMS Pharmaceutical Group Inc. has a significant indefinite...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The $45,943.92 order is for the pharmaceutical product ADCETRIS 50 MG VIALS, with a completion date of February 13, 2024. This delivery order is part of a larger indefinite delivery contract held by DMS Pharmaceutical Group with DLA to provide a variety of pharmaceutical and medical supplies to military treatment facilities worldwide, with a...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $44,728.26, covers the delivery of ADCETRIS 50 MG VIALS, a specialized pharmaceutical product, with a period of performance through November 30, 2023. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB...
- SPE2DB22D9367Indefinite Delivery Contract
- SPE2DB22D9367-SPE2DB24FSV93Delivery Order
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $61,258.56 contract is for the delivery of ADCETRIS 50 MG VIALS, a chemotherapy drug, with a completion date of February 20, 2024. The delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract 4600082013 with DLA, valued at up to $4,999,999 through 2025. This broader contract enables DLA to place delivery orders with DMS for a wide range of pharmaceutical products to support the medical supply needs of military health facilities globally. DMS Pharmaceutical Group has multiple prime vendor contracts to provide direct distribution of prescription drugs and pharmacy services to the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $61.3k | 1/29/24 |